Drug Trial Radar · NCT04028492
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
979
Actual
Start
Aug 20, 2019
Primary completion
Feb 21, 2025
Study completion Feb 21, 2025
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jul 22, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Conditions
- Idiopathic Gastroparesis
- Diabetic Gastroparesis
- Gastroparesis
Interventions
TradipitantDrug
BID
PlaceboDrug
BID
Open Label TradipitantDrug
BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 12 in the Biweekly Average of Daily Nausea Severity Score Using MMRM Model ITT PopulationTime frame: 12 weeks
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Peoria, Arizona
Vanda Investigational Site
Little Rock, Arkansas
Vanda Investigational Site
Chula Vista, California
Vanda Investigational Site
La Jolla, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
Maitland, Florida
Vanda Investigational Site
Palmetto Bay, Florida
Vanda Investigational Site
Tampa, Florida
Vanda Investigational Site
Morrow, Georgia
Vanda Investigational Site
Wauconda, Illinois
Vanda Investigational Site
West Des Moines, Iowa
Vanda Investigational Site
Wichita, Kansas
Vanda Investigational Site
Louisville, Kentucky
Vanda Investigational Site
Marrero, Louisiana
Vanda Investigational Site
Chevy Chase, Maryland
Vanda Investigational Site
Boston, Massachusetts
Vanda Investigational Site
Boston, Massachusetts
Vanda Investigational Site
Chesterfield, Missouri
Vanda Investigational Site
Las Vegas, Nevada
Vanda Investigational Site
Brooklyn, New York
Vanda Investigational Site
Charlotte, North Carolina
Vanda Investigational Site
Raleigh, North Carolina
Vanda Investigational Site
Columbus, Ohio
Vanda Investigational Site
Huber Heights, Ohio
Vanda Investigational Site
Edmond, Oklahoma
Vanda Investigational Site
Tulsa, Oklahoma
Vanda Investigational Site
Philadelphia, Pennsylvania
Vanda Investigational Site
Chattanooga, Tennessee
Vanda Investigational Site
Nashville, Tennessee
Vanda Investigational Site
Houston, Texas
Vanda Investigational Site
Houston, Texas
Vanda Investigational Site
Plano, Texas
Vanda Investigational Site
San Antonio, Texas
Vanda Investigational Site
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.